Hypertension Canada is the only national non-profit organization dedicated solely to the prevention and control of hypertension and its complications. Select from the following links to learn more about our:
We work with leading minds across medical and health disciplines to advance research and professional and public education, and with policy makers to ensure Canadians can avoid the potentially deadly complications of hypertension.
Seven and a half million people in Canada, about 1 in 5 adults, live with hypertension. Rising blood pressure over the long term causes atherosclerosis – the main risk for premature death (before the age of 65).
Canada has become a leader in the early detection of high blood pressure, its treatment and overall management. Much of this success has been attributed to the Hypertension Canada Guidelines – a set of clinical practice guidelines which are rigorously reviewed and updated annually, providing health care professionals with the most up-to-date recommendations and guidelines for the detection, treatment and control of hypertension.
Despite recent achievements, 1 in 3 people with hypertension has uncontrolled blood pressure, particularly high-risk patients with diabetes and kidney disease; and almost 1 in 5 people with hypertension is unaware of their condition.
Mission & Vision
Advancing health through the prevention and control of high blood pressure and its complications.
Canadians will have the healthiest and best-managed blood pressure in the world.
Hypertension Canada delivers against mission/vision by striving for excellence in three core service areas:
- Research: knowledge generation through research and innovation.
- Education: knowledge translation by turning discovery into practice.
- Advocacy: Creating supportive environments through healthy public policy and lifestyles.
Charitable Registration Number: 897016275RR0001
Board of Directors:
President and Chair of the Board
Vancouver, British Columbia
Dr. Nadia Khan is an Associate Professor of Medicine in the Division of General Internal Medicine at the University of British Columbia, a scientist at the Center for Health Evaluation and Outcomes Sciences (CHEOS), and a general internist at St. Paul’s Hospital in Vancouver. Dr. Khan was elected to Hypertension Canada’s Board in 2013.
Dr. Khan was a member of the Central Review Committee for the Canadian Hypertension Education Program (CHEP) from 2002 to 2013, and is Chair of Hypertension Canada’s Research Policy Committee.
Dr. Khan has been conducting research on hypertension epidemiology and gender and ethnic differences in cardiovascular disease and risk factors. She is currently funded to investigate chronic cardiovascular disease management in ethnic groups by a Career Scientist award from the Michael Smith Foundation for Health Research.
Mr. Glen Doucet is the Vice President, Advocacy and Public Affairs at the Canadian Pharmacists Association and has over 20 years’ expertise in government relations, policy development, strategic communications, and governmental regulatory processes. Mr. Doucet was elected to Hypertension Canada’s Board in 2014.
Mr. Doucet has served as a member of the senior management teams for the Canadian Medical Association and for the Canadian Diabetes Association where he led expansive advocacy campaigns that measurably improved patient access and outcomes in every province.
Mr. Doucet also has a passion for public service and politics. He has served as the National Director and Director of Policy for a major federal political party and in senior roles for leadership campaigns for two of the three leading federal political parties. He currently serves on the Board of the Canadian Skin Cancer Foundation.
Keeping Mr. Doucet grounded are his wife Dalaila, his ongoing pursuit to break eighty on the golf course and his pet goldfish Pilot.
Mr. Trevor Hudson is a senior manager in the Business Tax Services group with Deloitte and is focused primarily on the P3 infrastructure and the alternative energy sectors. Mr. Hudson was elected to Hypertension Canada’s Board in 2014.
Mr. Hudson has more than 14 years of professional experience in public practice with Deloitte and focuses primarily on the P3 infrastructure and the alternative and renewable energy sectors providing tax advisory services to Canadian and foreign based clients on matters relating to general tax planning, corporate reorganizations, mergers and acquisitions, tax accounting, and tax compliance reporting. Previously, Mr. Hudson worked in Deloitte’s assurance and advisory practice providing audit and accounting services to large public multinational clients as well as small medium and large private companies across a range of industries, including manufacturing, oil and gas, financial services, and not-for-profits. Mr. Hudson is the chair of Deloitte’s United Way employee campaign.
In addition to working in public practice, Mr. Hudson has also worked in the capital markets group of a large Canadian bank as well as for a large Canadian pension fund.
Mr. Hudson is a Chartered Professional Accountant and holds a Master of Business Administration degree, a Master of Tax degree, and a Bachelor of Science Degree in Biochemistry.
Mr. Hudson lives in Oakville, Ontario with his lovely wife and daughter and is an avid runner and hockey player.
Mr. Barry Arbus is a senior partner in the Torkin Manes Business Law Group, with a practice focused on mergers and acquisitions, especially international transactions. Mr. Arbus was elected to Hypertension Canada’s Board in 2012.
Mr. Arbus has represented both purchasers and vendors in numerous Canadian-based business transactions and acts as counsel to numerous European, American and international clients who are establishing businesses in Canada and acquiring Canadian-based operations. He also represents Canadian-based industries seeking to expand internationally.
A certified mediator and arbitrator, Mr. Arbus also holds a Master of Laws degree, a Bachelor of Laws degree and a Bachelor of Arts degree.
Mr. Arbus has served on the Board of Directors of several companies and a number of charitable organizations, including the Kidney Foundation of Canada, the Heart and Stroke Foundation of Ontario, the Starlight Foundation of Canada, and United Jewish Appeal. He has also been honoured with the Queen Elizabeth Medal in Recognition for Community Service.
Dr. Bell is a family physician and clinical researcher in Toronto, Canada. He is Assistant Professor in the Department of Family and Community Medicine, University of Toronto and on the active staff of the Humber River Hospital. He is a recipient of the Canadian College of Family Physicians Award of Excellence.
His activities include:
- Past Chair and Current Primary Panel – Canadian Cardiovascular Society Antiplatelet Guideline Committee
- Primary Panel – Canadian Cardiovascular Society Atrial Fibrillation Guideline Committee
- Thrombosis Canada – Board of Directors
- Hypertension Canada – Board of Directors
- Canadian Stroke Network Professional Development Committee
- Heart & Stroke Foundation Structural Heart Disease Council
Dr. Bell is the only primary care physician to chair a CCS guideline committee. His involvement in continuing medical education includes the development and presentation of many national projects. He has served as faculty and chair of countless committees and advisory boards dedicated to serving the common interests of the medical profession and the public. His research, commentaries and letters have been presented and published internationally.
Dr. Ross Feldman is the R.W. Gunton Professor of Therapeutics, Departments of Medicine and of Pharmacology & Physiology at the Schulich School of medicine and Dentistry, Western University. Dr. Feldman was elected to Hypertension Canada’s first Board in 2010, served as its first President to 2012, and then as Past-President to 2014.
Among past leadership positions in Hypertension Canada’s predecessor organizations, Dr. Feldman served as the first Chair of the Steering Committee of the Canadian Hypertension Education Program (CHEP). As well, he served as President of the Canadian Hypertension Society and as Treasurer of Blood Pressure Canada.
Dr. Feldman has taken leadership roles in a number of other scientific and professional organizations in the disciplines of medicine and pharmacology. He has been Vice- President of the American Society of Clinical Pharmacology and Therapeutics and Chair of the Clinical Pharmacology Division of the American Society of Pharmacology and Experimental Therapeutics. He has served as Chair of the Scientific Review Committee of the Heart and Stroke Foundation of Canada, Chair of the Research Committee of the Heart and Stroke Foundation of Ontario (HSFO), and as a member of the Board of Directors of the HSFO. He is the current Governor of the Ontario Chapter, American College of Physicians.
Dr. Janusz Kaczorowski is Professor and Research Director in the Department of Family and Emergency Medicine at the Université de Montréal. Dr. Kaczorowski was elected to Hypertension Canada’s Board in 2013.
Dr. Kaczorowski is a holder of the Dr. Sadok Besrour Chair in Family Medicine and the GlaxoSmithKline-Canadian Institutes of Health Research (CIHR) chair in Optimal Management of Chronic Disease. He directs the Evaluation, Health Care Systems and Services research theme at the Université de Montréal Hospital Research Centre (CRCHUM). He plays leadership roles in the hypertension, stroke and primary care research communities in Canada. He has an active, collaborative and multi-disciplinary research agenda that includes optimal use of therapeutics in primary care, primary prevention of cardiovascular disease and stroke, knowledge transfer, health services research and population health.
Dr. Kaczorowski has over 20 years’ experience in developing, coordinating, and completing all aspects of research studies in primary care. He has held a number of large grants both as principal investigator and co-investigator and has co-authored over 200 peer-reviewed articles.
David Lui is the Vice President of Marketing for Mark’s at Canadian Tire Corporation and has over 25 years’ experience in the retail industry. As an industry thought leader and member of the Retail Leadership Committee for the Canadian Marketing Association, he is passionate about the ever-changing retail market, supporting the needs of marketers, and has been recognized through multiple business awards for his excellence in the field.
David currently leads a team of marketing professionals to expand Mark’s identity through the development and implementation of innovative brand and marketing strategies. Over the course of his career, he has held senior executive roles with Global Apparel and Consumer Goods Brands, including Nygård, The North West Company, The Daiso and Esprit. In addition to his experience with these multinational corporations, he has dedicated his time to support non-profit organizations such as United Way Winnipeg, Take Pride Winnipeg!, Habitat For Humanity, Canadian Tire Jumpstart and the Canadian Diabetes Association.
As an avid competitive athlete, David has participated in destination marathons and competitive cycling events. David holds an MBA from the Ivey Business School at Western University.
Victoria, British Columbia
Ms. Dorothy Morris is a clinical nurse educator in cardiac surgery and coronary care at the Royal Jubilee Hospital, Victoria, British Columbia and Canadian Council of Cardiovascular Nurses (CCCN)’s National director for health promotion and advocacy. Ms. Morris was elected to Hypertension Canada’s Board in 2014.
Ms. Morris has co-authored and teaches a basic arrhythmia interpretation and management course, speaks on a variety of cardiovascular topics and has published a number of articles.
She has given numerous presentations at national and international conferences including the Canadian Association of Gerontology, The International Society of Hypertension and the Canadian Cardiovascular Congress. She contributes to the work of Hypertension Canada and the Canadian Institutes of Health Research / Heart and Stroke Foundation Chair’s Hypertension Advisory Committee.
In 2005, Ms. Morris received the award of excellence for nursing education from the college of registered nurses of British Columbia and the clinical cardiovascular excellence award from CCCN. She has also been the recipient of an award of excellence from Hypertension Canada and award of merit for workplace health innovation from the health employers association of British Columbia.
Ms. Morris has a keen interest in cardiovascular disease risk factors, health advocacy and in continuing nursing education initiatives.
Dr. Raj Padwal is a physician, epidemiologist and health services researcher, with expertise in clinical pharmacology, general internal medicine and clinical epidemiology. He is presently a full Professor in the Division of Internal Medicine at the University of Alberta.
Raj received his medical degree in 1995 from the University of Saskatchewan. He completed his Internal Medicine training at the University of Alberta before a research fellowship in Clinical Pharmacology at the University of Toronto, where he also earned his Master of Science in Clinical Epidemiology. As an academic internist and a health services researcher with an interest in cardiovascular risk management, his specific areas of interest include hypertension, blood pressure measurement and bariatric (obesity) care. He has published 143 peer-reviewed papers and 10 book chapters.
Raj has been actively engaged in Hypertension Canada and its heritage organizations since 2004, when he first joined the the CHEP Recommendations Task Force of which is now Co-Chair. He serves also as a member of the CHEP Central Review Committee, and of Hypertension Canada’s Operations Committee. Among his many professional awards, he received Hypertension Canada’s Senior Investigator Award in 2014.
Dr. Ernesto Schiffrin is Physician-in-Chief of the Jewish General Hospital, holds a Canada Research Chair in Hypertension and Vascular Research at the Lady Davis Institute for Medical Research, and is Professor and Vice-Chair (Research), Department of Medicine, McGill University. Dr. Schiffrin was elected to Hypertension Canada’s Board in 2012, and has held the office of President since 2013.
Dr. Schiffrin served as Secretary-Treasurer (1988-1991) and President of the Canadian Hypertension Society (1991-1992), Vice-Chair (2000-2002) and Chair of the High Blood Pressure Research Council of the American Heart Association (2002-2004), President of the InterAmerican Society of Hypertension (2005-2007) and President of the Quebec Hypertension Society (2009-2011). Dr. Schiffrin was Vice-President (2010-2012), President (2012-2014), and is now the immediate Past President of the International Society of Hypertension. Dr. Schiffrin has been Associate Editor of Hypertension (AHA journal) since 2003. Dr. Schiffrin was a member (2006-2009) and President (2009-2012) of the Committee of Chairs of Departments of Specialty Medicine for the Island of Montreal.
Dr. Schiffrin received the Young Investigator Award of the Canadian Hypertension Society in 1985, the Senior Investigator Award of the Canadian Society of Internal Medicine in 2003, and the Distinguished Service Award of the Canadian Hypertension Society in 2004. He was elected Fellow of the Royal Society of Canada in 2006, and received the 2007 Irvine Page-Alva Bradley Lifetime Achievement Award of the High Blood Pressure Research Council of the American Heart Association and the 2010 Bjorn Folkow Award of the European Society of Hypertension. He was appointed Member of the Order of Canada in July 2010. He was awarded the 2011 Excellence Award in Hypertension Research by the American Heart Association, a Queen Elizabeth Diamond Jubilee Medal in 2013, the 2013 Robert Tigerstedt Distinguished Scientist Award by the American Society of Hypertension, and the 2013 Canadian Cardiovascular Society Research Achievement Award.
Dr. Sheldon Tobe has been a Staff Nephrologist at Sunnybrook since 1993 and a Professor of Medicine at the University of Toronto since July 1, 2014. Dr. Tobe was elected to Hypertension Canada’s Board in 2012.
On July 1, 2013, Dr. Tobe was named the Heart and Stroke Foundation/Northern Ontario School of Medicine Chair, Aboriginal and Rural Health Research. In his career, he mixes clinical care, teaching, peer reviewed and investigator initiated research, and an interest in administration as it relates to improving health care outcomes.
Dr. Tobe chaired the Sunnybrook Department of Medicine’s Research Committee for 5 years to 2009 and, in 2006, created an ambulatory course in Hypertension and Global Cardiovascular Risk for post graduate medical trainees. He is the recipient of teaching awards including the Sunnybrook Health Sciences Centre Department of Medicine’s 1996 Young Clinician Award, 2002 In-Patient Teaching Award and 2011 Continuing Education Award. He also received the University of Toronto’s 2009 Ambulatory Care Elective Teaching award and the Sunnybrook Education Advisory Council 2012 Education Beyond Sunnybrook Award. In 2010, the Heart and Stroke Foundation of Ontario presented Dr Tobe with an award for Volunteer Excellence.
Dr. Tobe joined the Canadian Hypertension Education Program (CHEP) in 1999 on the renal subgroup and became the Chair of the Recommendations Task Force in 2005 and then Chair of CHEP from 2009 to 2012. In 2008, Blood Pressure Canada presented Dr. Tobe with the Certificate of Excellence in recognition for his outstanding efforts in the Canadian Hypertension Education Program and innovative research efforts in improving the management of hypertension.
Dr. Tobe is co-applicant and operational lead on the DREAM-GLOBAL (Diagnosing hypeRtension-Engaging Action and Management in Getting LOwer Blood pressure in Aboriginal and Low and middle income countries) study. This five-year study was funded in 2012 through the Global Alliance of Chronic Disease, Grand Challenges Canada and the Canadian Institutes of Health Research (CIHR) to implement hypertension clinical practice guidelines leveraging short message service (SMS) technologies in Canada’s Aboriginal population and in a community in Tanzania.
Quebec City, Quebec
Dr. Guy Tremblay combines his cardiology practice with his teaching position as Clinical Professor of Medicine at Laval University. Spurred by his interest in promotion cardiovascular health, Dr. Tremblay has served since 1978 as consulting cardiologist for the Public Health Centre, and active member of Clinical practice guideline initiatives, with Hypertension Canada and the Canadian Cardiovascular Society.
In recent years, Dr. Tremblay has focused his attention on closing the gap between medical knowledge and clinical practice. He has been proactive in assuming a leading role in encouraging the widespread dissemination and adoption of clinical practice guidelines. To facilitate this leadership in knowledge transfer for cardiovascular promotion and prevention, he has served on boards of numerous scientific societies (Canadian Cardiovascular Society, Hypertension Canada, among others) and has collaborated on numerous committees of scientific societies (RCPSC, CLIMOA, ACQ, and others).
His research interest is Cardiovascular Risk evaluation, as a medical consultant for Insurance and Reinsurance companies, while promoting clinical risk evaluation with appropriate Canadian risk engines, such as SCORE CANADA.
Dr. Ross Tsuyuki is a Professor of Medicine (Cardiology) and director of the Epidemiology Coordinating and Research (EPICORE) Centre (a health research coordinating centre) and an Adjunct Faculty Member of the School of Public Health, both at the University of Alberta. He has been a Clinical Pharmacotherapy Practitioner in the Heart Function Clinic at the University of Alberta Hospital since 1996. Dr. Tsuyuki was elected to Hypertension Canada’s first Board in 2010.
Dr. Tsuyuki’s interests are in clinical trials design and execution, hypertension, heart failure, community practice-based research, cardiovascular risk factors, and in the provision of support for clinical researchers through the EPICORE Centre. Dr. Tsuyuki has received several awards for teaching, as well as an appointment as a Fellow of the Canadian Society of Hospital Pharmacists and the American College of Cardiology. In 2005, he was recognized as the Canadian Pharmacist of the Year by the Canadian Pharmacists Association.
Chief Executive Officer
Angelique Berg is a business development and marketing executive with over 20 years’ experience spanning both profit and non-profit health sectors. Her leadership experience includes roles in public and government relations, program and volunteer management, and over 15 years in fundraising.
Angelique has held executive positions in the charitable health sector, including Osteoporosis Canada, the Canadian Diabetes Association, and the Canadian Orthopaedic Foundation. She has served on health sector collaborations that accelerated health care system and patient care improvements, including the Wait Times Alliance, the Alliance for the Canadian Arthritis Program, and the Bone and Joint Decade Canada. An active ambassador for the sector, she has served as a Steering Committee member of the Health Charities Coalition of Canada, and is a member of the Association of Fundraising Professionals and the Canadian Society for Association Executives. Angelique volunteers with the Canadian Orthopaedic Association, as well as with personal interest causes, including Halton Region’s Project Autism, and a WWII RCAF veterans’ association.
Angelique is a strategic, collaborative leader with a proven track record of achieving revenue targets through creating high performance teams. She is known for her dedication to excellence in charitable management, and for her passion to improve health for a thriving, productive society.
Hypertension Canada Awards
The annual awards recognize a distinguished record of substantial contributions by individuals or organizations that have increased prevention and/or improved control of blood pressure in Canada.
Hypertension Innovations Award
The new annual award recognizes a member or organization that implements innovative approaches in knowledge translation and education related to hypertension and/or primary prevention.
George Fodor Award
The George Fodor Award recognizes a distinguished record of substantial contributions by individuals or organizations that have increased prevention and/or improved control of blood pressure in Canada. Contributions worthy of this prestigious award are expected to be broad in scope (i.e., national) and enduring over time, and to have had a substantive impact.
- 2019 Call for Nominations for the George Fodor Award (.pdf)
- Download 2017 George Fodor Award Recipient (.pdf)
- Download 2014 George Fodor Award Recipient (.pdf)
Distinguished Service Award
The Distinguished Service Award recognizes a long-standing distinguished record of service to Hypertension Canada by an individual. A nominee must have made significant voluntary service contributions to Hypertension Canada and prolonged contributions to the Canadian Hypertension Society, Blood Pressure Canada and/or Hypertension Canada Guidelines over their career.
- 2019 Call for Nominations for the Distinguished Service Award (.pdf)
- Download 2017 Distinguished Service Award Recipient (.pdf)
- Download 2016 Distinguished Service Award Recipient (.pdf)
- Download 2015 Distinguished Service Award Recipient(.pdf)
- Download 2014 Distinguished Service Award Recipient (.pdf)
Senior Investigator Award
The Senior Investigator Award recognizes research in hypertension or blood pressure by an individual. A nominee must have made significant contributions to the advancement and extension of knowledge in basic, clinical, health services or population-based research specifically relating to hypertension or blood pressure.
- 2019 Call for Nominations for the Senior Investigator Award (.pdf)
- Download 2017 Senior Investigator Award Recipient (.pdf)
- Download 2016 Senior Investigator Award Recipient (.pdf)
- Download 2015 Senior Investigator Award Recipient (.pdf)
- Download 2014 Senior Investigator Award Recipients (.pdf)
Jacques de Champlain New Investigator Award
The Jacques de Champlain New Investigator Award recognizes excellence in the field of hypertension or blood pressure research by a new investigator, who has not exceeded a time period of 10 years from the first appointment as an independent investigator. A nominee must have made significant contributions to the advancement and extension of knowledge in basic, clinical, health services or population-based research specifically relating to hypertension or blood pressure.
- 2019 Call for Nominations for the Jacques de Champlain New Investigator Award (.pdf)
- Download 2017 Jacques de Champlain New Investigator Award Recipient (.pdf)
- Download 2014 Jacques de Champlain New Investigator Award Recipient (.pdf)
Certificates of Excellence
Throughout Canada, community, provincial, regional or national initiatives and ongoing programs of high blood pressure prevention and control are instrumental in improving the control of blood pressure. Many of these initiatives are led and contributed to by community-based organizations, individuals and volunteer efforts. These activities are essential to the health of the average Canadian by potentially lowering cardiovascular disease, but are rarely acknowledged. The Certificates of Excellence are presented to these worthy individuals or organizations in recognition of their outstanding efforts and contributions in Canada through increased public awareness, prevention or control of hypertension.
- 2019 Call for Nominations for the Certificate of Excellence Award (.pdf)
- Download 2017 Certificate of Excellence Recipients (.pdf)
- Download 2016 Certificate of Excellence Recipients (.pdf)
- Download 2015 Certificate of Excellence Recipients (.pdf)
- Download 2014 Certificate of Excellence Recipients (.pdf)